Evidence map›Paper›PMID 28445147›Full record

ArticleOncotarget2017

Identification of rs7350481 at chromosome 11q23.3 as a novel susceptibility locus for metabolic syndrome in Japanese individuals by an exome-wide association study.

Yoshiji Yamada, Jun Sakuma, Ichiro Takeuchi, Yoshiki Yasukochi, Kimihiko Kato, Mitsutoshi Oguri, Tetsuo Fujimaki, Hideki Horibe, Masaaki Muramatsu, Motoji Sawabe and 8 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Multi-Ancestry Mendelian Randomization Reveals Lipid-Associated Genetic Risk Factors for COPD.International journal of chronic obstructive pulmonary disease · 2025
    Pooled it
  2. Trial
  3. Article
  4. Ras and Rab Interactor 3: From Cellular Mechanisms to Human Diseases.Frontiers in cell and developmental biology · 2022
    Review
  5. Review
  6. TheFrontiers in oncology · 2021
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 1 country.

Yoshiji YamadaDepartment of Human Functional Genomics, Advanced Science Research Promotion Center, Mie University, Tsu, Japan.
Jun SakumaCREST, Japan Science and Technology Agency, Kawaguchi, Japan.
Ichiro TakeuchiCREST, Japan Science and Technology Agency, Kawaguchi, Japan.
Yoshiki YasukochiDepartment of Human Functional Genomics, Advanced Science Research Promotion Center, Mie University, Tsu, Japan.
Kimihiko KatoDepartment of Human Functional Genomics, Advanced Science Research Promotion Center, Mie University, Tsu, Japan.
Mitsutoshi OguriDepartment of Human Functional Genomics, Advanced Science Research Promotion Center, Mie University, Tsu, Japan.
Tetsuo FujimakiDepartment of Cardiovascular Medicine, Inabe General Hospital, Inabe, Japan.
Hideki HoribeDepartment of Cardiovascular Medicine, Gifu Prefectural Tajimi Hospital, Tajimi, Japan.
Masaaki MuramatsuDepartment of Molecular Epidemiology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
Motoji SawabeSection of Molecular Pathology, Graduate School of Health Care Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Yoshinori FujiwaraResearch Team for Social Participation and Community Health, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.
Yu TaniguchiResearch Team for Social Participation and Community Health, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.
Shuichi ObuchiResearch Team for Promoting Support System for Home Care, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.
Hisashi KawaiResearch Team for Promoting Support System for Home Care, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.
Shoji ShinkaiResearch Team for Social Participation and Health Promotion, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.
Seijiro MoriCenter for Promotion of Clinical Investigation, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.
Tomio AraiDepartment of Pathology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.
Masashi TanakaDepartment of Clinical Laboratory, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.
Tokyo Metropolitan Institute of Gerontology · JPJapan Science and Technology Agency · JPTokyo Metropolitan Geriatric Hospital · JPMie University · JPTokyo Medical and Dental University · JPGifu Prefectural Tajimi Hospital · JPMeitetsu Hospital · JPShowa Inan General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have performed exome-wide association studies to identify genetic variants that influence body mass index or confer susceptibility to obesity or metabolic syndrome in Japanese. The exome-wide association study for body mass index included 12,890 subjects, and those for obesity and metabolic syndrome included 12,968 subjects (3954 individuals with obesity, 9014 controls) and 6817 subjects (3998 individuals with MetS, 2819 controls), respectively. Exome-wide association studies were performed with Illumina HumanExome-12 DNA Analysis BeadChip or Infinium Exome-24 BeadChip arrays. The relation of genotypes of single nucleotide polymorphisms to body mass index was examined by linear regression analysis, and that of allele frequencies of single nucleotide polymorphisms to obesity or metabolic syndrome was evaluated with Fisher's exact test. The exome-wide association studies identified six, 11, and 40 single nucleotide polymorphisms as being significantly associated with body mass index, obesity (P <1.21 × 10-6), or metabolic syndrome (P <1.20 × 10-6), respectively. Subsequent multivariable logistic regression analysis with adjustment for age and sex revealed that three and five single nucleotide polymorphisms were related (P < 0.05) to obesity or metabolic syndrome, respectively, with one of these latter polymorphisms-rs7350481 (C/T) at chromosome 11q23.3-also being significantly (P < 3.13 × 10-4) associated with metabolic syndrome. The polymorphism rs7350481 may thus be a novel susceptibility locus for metabolic syndrome in Japanese. In addition, single nucleotide polymorphisms in three genes (CROT, TSC1, RIN3) and at four loci (ANKK1, ZNF804B, CSRNP3, 17p11.2) were implicated as candidate determinants of obesity and metabolic syndrome, respectively.

Indexed as

Chromosomes, Human, Pair 11ExomeGenetic MarkersPolymorphism, Single NucleotideAsian PeopleBody Mass IndexCase-Control StudiesFemaleFollow-Up StudiesGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMaleMetabolic SyndromeMiddle AgedObesityGenetic Markersbody mass indexexome-wide association studygeneticsmetabolic syndromeobesity

Identifiers

PMID28445147
PMCPMC5503614
OpenAlexW2604934557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.